The use of EEG in Alzheimer's disease, with and without scopolamine - A pilot study

Clinical Neurophysiology

Volumn 121, Issue 6, 2010, Pages 836-841

  Snaedal, J ^a   Johannesson, G H ^b   Gudmundsson, Th E ^a   Gudmundsson, S ^b   Pajdak, T H ^b   Johnsen, K ^b  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^b Mentis Cura   (Iceland)

Author keywords

Alzheimer's disease; Electroencephalography; Mild cognitive impairment; Scopolamine

Indexed keywords

SCOPOLAMINE;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE COURSE; ELECTROENCEPHALOGRAM; ENTROPY; FEMALE; HUMAN; MALE; MILD COGNITIVE IMPAIRMENT; PATTERN RECOGNITION; PILOT STUDY; PREDICTION; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN MAPPING; CEREBRAL CORTEX; COGNITION DISORDERS; DISEASE PROGRESSION; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PATIENT SELECTION; PATTERN RECOGNITION, AUTOMATED; PILOT PROJECTS; SCOPOLAMINE; SIGNAL PROCESSING, COMPUTER-ASSISTED;

EID: 77952419057     PISSN: 13882457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinph.2010.01.008     Document Type: Article

References (29)

1. Agnoli A., Martucci N., Manna V., Conti L., and Fioravanti M. Effect of cholinergic and anitcholinergic drugs on short-term memory in Alzheimer's dementia: a neuropsychological and computerized electroenchephalographic study. Clin Neuropharmacol 6 (1983) 311-323
2. Burg JP. Maximum entropy spectral analysis. PhD thesis. California, USA: Stanford University; 1975.
3. Buscema M., Rossini P., Babiloni C., and Grossi E. The IFAST model, a novel parallel nonlinear EEG analysis technique, distinguishes mild cognitive impairment and Alzheimer's disease patients with high degree of accuracy. Artif Intell Med 40 (2007) 127-141
4. Christensen H., Maltby N., Jorm A.F., Creasey H., and Broe G.A. Cholinergic 'blockade' as a model of the cognitive deficits in Alzheimer's disease. Brain 115 (1992) 1681-1699
5. Coyle J.T., Price D.L., and Delong M.R. Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 219 (1983) 1184-1190
6. Duda R.O., Hart P.E., and Stork D.G. Pattern classification. 2nd ed. (2001), John Wiley & Sons, Inc., New York, USA
7. Ebert U., and Kirch W. Review - scopolamine model of dementia: electroencephalogram findings and cognitive performance. Eur J Clin Invest 28 (1998) 944-949
8. Eskandar O.S., Eckford S.D., and Whittaker K.W. Treatment of overactive bladder (OBA) with anti-cholinergic drugs and the risk of glaucoma. J Obstet Gynaecol 25 (2005) 419-421
9. Folstein M.F., Folstein S.E., and McHugh P.R. "Mini-mental state" - a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12 (1975) 189-198
10. Gauthier S., Reisberg B., Zaudig M., Petersen R.C., Ritchie K., Broich K., et al. Mild cognitive impairment. Lancet 367 (2006) 1262-1270
11. Goedert M., and Spillantini M.G. A century of Alzheimer's disease. Science 314 (2006) 777-781
12. Gudmundsson S., Runarsson T.P., Sigurdsson S., Eiriksdottir G., and Johnsen K. Reliability of quantitative EEG features. Clin Neurophysiol 118 (2007) 2162-2171
13. Jackson C.E., and Snyder P.J. Electroencephalography and event-related potentials as biomarkers of mild cognitive impairment and mild Alzheimer's disease. Alzheimers Dement 4 (2008) S137-S143
14. Jelic V., Johansson S.E., Almkvist O., Shigeta M., Julin P., Nordberg A., et al. Quantitative electroencephalography in mild cognitive impairment: longitudinal changes and possible prediction of Alzheimer's disease. Neurobiol Aging 21 (2000) 533-540
15. Jeong J.S. EEG dynamics in patients with Alzheimer's disease. Clin Neurophysiol 115 (2004) 1490-1505
16. Johannesson GH, Gudmundsdottir IR, Helgason J, Ofeigsson BG, Hrafnkelsdottir K, Olafsson DR, et al. The initial effects of scopolamine on the electroencephalogram in healthy human subjects. In: IEEE EMBS 25th annual international conference; 2003.
17. Knopman D.S., Boeve B.F., and Petersen R.C. Essentials of the proper diagnoses of mild cognitive impairment, dementia, and major subtypes of dementia. Mayo Clin Proc 78 (2003) 1290-1308
18. McKann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M., et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health & Human Services Task Force on Alzheimer's disease. Neurology 34 (1984) 939-944
19. Nestor P.J., Scheltens P., and Hodges J.R. Advances in the early detection of Alzheimer's disease. Nat Rev Neurosci (2004) S34-S41
20. Neufeld M.Y., Rabey M.J., Parmet Y., Sifris P., Treves T.A., and Korczyn A.D. Effects of a single intravenous dose of scopolamine on the quantitative EEG in Alzheimer's disease patients and age-matched controls. Electroencephalogr Clin Neurophysiol 91 (1994) 407-412
21. Nobili L., and Sannita W.G. Cholinergic modulation, visual function and Alzheimer's disease. Vision Res 37 (1997) 3559-3571
22. Petersen R.C. Mild cognitive impairment as a diagnostic entity. J Intern Med 256 (2004) 183-194
23. Prichep L.S., John E.R., Ferris S.H., Rausch L., Fang Z., Cancro R., et al. Prediction of longitudinal cognitive decline in normal elderly with subjective complaints using electrophysiological imaging. Neurobiol Aging 27 (2006) 471-481
24. Reisberg B., Ferris S.H., Deleon M.J., and Crook T. The global deterioration scale for assessment of primary degenerative dementia. Am J Psychiat 139 (1982) 1136-1139
25. Rossini P.M., Del Percio C., Pasqualetti P., Cassetta E., Binetti G., Dal Forno G., et al. Conversion from mild cognitive impairment to Alzheimer's disease is predicted by sources and coherence of brain electroencephalography rhythms. Neuroscience 143 (2006) 793-803
26. Snædal J, Gu{eth}mundsson G, Jónsson JE, Jónsdóttir J. Faraldsfræ{eth}ileg rannsókn á vitrænni getu aldra{eth}ra á tveimur a{eth}skildum svæ{eth}um á Íslandi. Læknabla{eth}i{eth} 1997;83:646-53.
27. Terry A.V., and Buccafusco J.J. The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: Recent challenges and their implications for novel drug development. J Pharmacol Exp Ther 306 (2003) 821-827
28. Tómasson K. Athugun á glöpum hjá öldru{eth}um og áfengissjúklingum me{eth} au{eth}veldu stö{eth}lu{eth}u prófi borin saman vi{eth} mat starfsfólks. Læknabla{eth}i{eth} 1986;72:246-59.
29. Winblad B., Palmer K., Kivipelto M., Jelic V., Fratiglioni L., Wahlund L.O., et al. Mild cognitive impairment - beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 256 (2004) 240-246